Skip to main content

Table 5 Demographic characteristic of 53 patients with CLLTs

From: Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma

Variables Single segment (n = 38) Multiple segments (n = 15) P-value
Age (years) 49.6 ± 13.0 55.0 ± 14.2 0.155
Gender, M:F 37:1 15:0 0.526
Liver cirrhosis    0.362
 Present 31 (81.6%) 12 (80.0%)
 Absent 7 (18.4%) 3 (20.0%)
AFP (ng/ml) 209.2 ± 350.0 246.0 ± 409.3 0.591
Tumor size (cm)    0.560
 < 5 26 (68.4%) 9 (66.7%)
 ≥ 5 12 (31.6%) 6 (33.3%)
Tumor nodule number    0.986
 Single 33 (86.8%) 13 (86.7%)
 Multiple (≥ 2) 5 (13.2%) 2 (13.3%)
MVI    0.531
 Present 5 (13.2%) 3 (20.0%)
 Absent 33 (86.8%) 12 (80.0%)
Differentiation grade#    0.879
 I–II 35 (92.1%) 14 (93.3%)
 III–IV 3 (7.9%) 1 (6.7%)
Surgical methods    0.328
 Mesohepatectomy 10 (26.3%) 6 (100%)
 Extended left/right hepatectomy 28 (73.7%) 9 (0%)
 Duration operation (min) 197.1 ± 75.7 223.4 ± 49.6 0.291
 Blood loss (ml) 296.0 ± 220.9 403.6 ± 621.6 0.362
Surgical margin (cm)    0.713
 < 1.0 6 (15.8%) 3 (20.0%)
 ≥ 1.0 32 (84.2%) 12 (80.0%)
Overall complications 9 (23.7%) 4 (26.7%) 0.820
 Ascites (Grade I) 5 (13.2%) 3 (20.0%)
 Pulmonary inflammation (Grade II) 3 (7.9%) 1 (6.7%)
 Wound infection (Grade I) 1 (2.6%) 0 (0%)
 In-hospital mortality 0 (0%) 0 (0%)